These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7660484)

  • 1. Atypical Escherichia coli in urinary tract infection.
    Bhat KG; Bhat MG
    Trop Doct; 1995 Jul; 25(3):127. PubMed ID: 7660484
    [No Abstract]   [Full Text] [Related]  

  • 2. [Susceptibility to antibiotics of Escherichia coli isolated from community-acquired urinary tract infections].
    Fabre R; Mérens A; Lefebvre F; Epifanoff G; Cerutti F; Pupin H; Tardif D; Cavallo JD; Ternois I
    Med Mal Infect; 2010 Oct; 40(10):555-9. PubMed ID: 20417046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: a prospective study.
    Sotto A; De Boever CM; Fabbro-Peray P; Gouby A; Sirot D; Jourdan J
    J Clin Microbiol; 2001 Feb; 39(2):438-44. PubMed ID: 11158087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiresistant Escherichia coli isolated from women with community-acquired urinary tract infections in the Gaza Strip.
    Astal Z; Sharif FA; Abdallah SA; Fahd MI
    J Chemother; 2002 Dec; 14(6):637-8. PubMed ID: 12583559
    [No Abstract]   [Full Text] [Related]  

  • 5. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates.
    Caron F; Etienne M
    Am J Med; 2010 Mar; 123(3):e13. PubMed ID: 20193811
    [No Abstract]   [Full Text] [Related]  

  • 6. Ten-year survey of quinolone resistance in Escherichia coli causing urinary tract infections.
    Pérez-Trallero E; Urbieta M; Jimenez D; García-Arenzana JM; Cilla G
    Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):349-51. PubMed ID: 8354301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The sensitivity of the uropathogenic Escherichia coli strains to antibiotics, bacteriophages and bactericidal serum activity].
    Drulis-Kawa Z; Weber-Dabrowska B; Lewczyk E; Jankowski S; Doroszkiewicz W
    Pol Merkur Lekarski; 2002 Dec; 13(78):470-2. PubMed ID: 12666443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Round table conference on non-obstructive urinary tract infections in children.
    Andersen HJ; Bergström T; Hanson LA; Lincoln K; Nyegaard A; Orskov F; Orskov I
    Acta Paediatr Scand; 1967; ():Suppl 177:42+. PubMed ID: 4871006
    [No Abstract]   [Full Text] [Related]  

  • 9. Increasing in vitro resistance of E coli to TMP/SMX.
    Postgrad Med; 2001 Aug; 110(2 Suppl):5-8; discussion 26-7. PubMed ID: 19667569
    [No Abstract]   [Full Text] [Related]  

  • 10. Urinary tract infections and a multidrug-resistant Escherichia coli clonal group.
    Barlam T; Moellering R
    N Engl J Med; 2002 Feb; 346(7):535-6. PubMed ID: 11858221
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro resistance of E coli to TMP/SMX and clinical failure.
    Postgrad Med; 2001 Aug; 110(2 Suppl):9-10; discussion 26-7. PubMed ID: 19667570
    [No Abstract]   [Full Text] [Related]  

  • 12. Association between fluoroquinolone resistance and resistance to other antimicrobial agents among Escherichia coli urinary isolates in the outpatient setting: a national cross-sectional study.
    Hwang TJ; Hooper DC
    J Antimicrob Chemother; 2014 Jun; 69(6):1720-2. PubMed ID: 24521853
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum-beta-lactamase-producing Escherichia coli with amoxicillin/clavulanate: case report and characterization of the isolate.
    Lagacé-Wiens PR; Nichol KA; Nicolle LE; DeCorby M; McCracken M; Mulvey MR; Zhanel GG
    J Antimicrob Chemother; 2006 Jun; 57(6):1262-3. PubMed ID: 16565157
    [No Abstract]   [Full Text] [Related]  

  • 14. [Urinary tract infection by multiresistant Escherichia coli and Klebsiella pneumoniae: case report].
    Martín-Pozo Á; Oteo J; Sáez D; Alós JI
    Rev Esp Quimioter; 2012 Dec; 25(4):295-6. PubMed ID: 23303263
    [No Abstract]   [Full Text] [Related]  

  • 15. Susceptibility of Escherichia coli with capsular antigen K1 isolated from urinary tract infection on the joint action of cefotaxime and normal human serum.
    Jankowski S; Franiczek R
    Nephron; 1994; 68(4):519-20. PubMed ID: 7870242
    [No Abstract]   [Full Text] [Related]  

  • 16. Urinary tract infections and a multidrug-resistant Escherichia coli clonal group.
    Petrof EO; Schwartz DN; Quinn JP
    N Engl J Med; 2002 Feb; 346(7):535-6. PubMed ID: 11858220
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical implications. In vitro resistance of E coli to TMP/SMX.
    Postgrad Med; 2001 Aug; 110(2 Suppl):11-5; discussion 26-7. PubMed ID: 19667571
    [No Abstract]   [Full Text] [Related]  

  • 18. Ribotyping differentiates relapse from reinfection in the treatment failures of Escherichia coli urinary tract infections in children.
    Bingen E; Rangaraj M; Safran C
    Diagn Microbiol Infect Dis; 1994 Apr; 18(4):263-5. PubMed ID: 7924224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging Escherichia coli O25b/ST131 clone predicts treatment failure in urinary tract infections.
    Can F; Azap OK; Seref C; Ispir P; Arslan H; Ergonul O
    Clin Infect Dis; 2015 Feb; 60(4):523-7. PubMed ID: 25378460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic resistance pattern of urinary tract isolates of Escherichia coli from Kumaun region.
    Rawat V; Umesh ; Paul P
    J Commun Dis; 2010 Mar; 42(1):63-6. PubMed ID: 22468553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.